• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Mentice

13.50 SEK+1.50 %13.7. klo 16.06
Less than 1K followers

MNTC

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.50 %
+7.14 %
+1.50 %
-2.17 %
+1.12 %
-2.37 %
-67.07 %
-84.25 %
-79.78 %

Mentice operates in the medical technology sector. The company develops medical instruments for endovascular simulation and for training sessions in surgery. The programs are developed for use in educational purposes among hospitals and institutes. The largest operations are found in North America and Europe. In addition to the main business, opportunities for leasing, support, and technical service are offered. The headquarters are located in Gothenburg.

Read more
Market cap
379.7M SEK
Turnover
1.12K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
23.7.
2026

Interim report Q2'26

10.11.
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release10.07.2026 klo 14.05

Mentice to Present Q2 2026 Interim Report via Webcast

Mentice
Press release09.07.2026 klo 18.45

DNB Carnegie Access: Mentice: Don’t stop delivering – Q2 preview

Mentice
Regulatory press release01.07.2026 klo 21.00

Correction: Missing MAR label in earlier Press Release - Mentice secures $2.4M in several orders from one Top 20 Global MedTech Company within Interventional Cardiology

Mentice

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release30.06.2026 klo 09.05

DNB Carnegie Access: Mentice: Top 20 medtech order further reinforces momentum in MDI

Mentice
Regulatory press release29.06.2026 klo 19.00

Mentice secures $2.4M in several orders from one Top 20 Global MedTech Company in Interventional Cardiology, focused on Structural Heart Disease

Mentice
Press release01.06.2026 klo 21.00

Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning

Mentice
Regulatory press release26.05.2026 klo 23.00

Communique from annual general meeting in Mentice AB

Mentice
Press release08.05.2026 klo 08.00

DNB Carnegie Access: Mentice: Three consecutive quarters of improvement – Q1 review

Mentice
Press release07.05.2026 klo 09.30

DNB Carnegie Access: Mentice: Reinforcing the recovery narrative – Q1 initial

Mentice
Regulatory press release07.05.2026 klo 08.00

INTERIM REPORT JAN–MAR 2026

Mentice
Regulatory press release24.04.2026 klo 22.15

Annual shareholders’ meeting in Mentice AB

Mentice
Press release23.04.2026 klo 11.00

Mentice AB Publishes Annual and Sustainability Report for 2025

Mentice
Press release21.04.2026 klo 10.00

Mentice to Present Q1 2026 Interim Report via Webcast

Mentice
Press release20.04.2026 klo 19.27

DNB Carnegie Access: Mentice: MDI set to drive continued momentum – Q1 preview

Mentice
Press release23.03.2026 klo 21.00

Mentice Appoints Rick van Veen as Chief Financial Officer and Announces Changes to the Executive Management Group

Mentice
Press release27.02.2026 klo 09.19

DNB Carnegie Access: Mentice: Ending 2025 on a high note – Q4 review

Mentice
Regulatory press release26.02.2026 klo 22.00

Communique from extraordinary shareholders’ meeting in Mentice AB

Mentice
Press release26.02.2026 klo 09.17

DNB Carnegie Access: Mentice: Firing on all cylinders – Q4 initial take

Mentice
Regulatory press release26.02.2026 klo 08.00

Mentice publishes the company’s year-end report for the period January–December 2025

Mentice
Press release12.02.2026 klo 16.00

Mentice to Present the Company's Year-End Q4 Report 2025 via Webcast

Mentice